Wegovy Cost Without Insurance: What Cash Pay Looks Like

Last reviewed: May 12, 2026 Last updated: May 12, 2026

Written by: Jay Hastings , CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

Paying cash: what to expect

Stripping insurance out of the equation changes the Wegovy math considerably. Cash-pay patients do not get the benefit of formulary negotiation or plan rebates, so the number they face is closer to raw list. Before assuming that is the whole story, though, it helps to see which levers still exist and how compounded pricing sits alongside the brand.

Browse the full PlexusDx Education Hub library on GLP-1 therapies, weight protocols, and metabolic genetics.

The list price you'd face uncovered

Wegovy list price is approximately $1,349 per month at U.S. list as of April 2026, per Novo Nordisk's published pricing. Without insurance and without a manufacturer savings card, that list price is roughly what a cash-pay patient encounters at most U.S. pharmacies. It is the ceiling most self-pay conversations start from, which is why the levers below matter so much.

Levers that lower a cash bill

Pharmacy discount cards

Independent platforms such as GoodRx and SingleCare publish coupon prices that vary by pharmacy and change frequently. For a cash payer, comparing these across nearby pharmacies can shave the bill, even if it rarely erases it.

Manufacturer programs

Novo Nordisk's savings card is built for eligible commercially-insured patients, so an uninsured cash payer typically will not qualify. It is still worth confirming eligibility rather than assuming, since terms change over time.

Compounded pharmacy pricing

Licensed 503A compounding pharmacies legally prepared compounded semaglutide and tirzepatide during the FDA-declared shortages. The semaglutide shortage resolved in late 2024 and tirzepatide in early 2025, narrowing but not closing the pathway. Compounded formulations remain available where clinically justified, are priced separately, and are legally and factually different from the brand, not generics. For cash payers, they often present a different price structure worth reviewing with a clinician.

When self-pay makes sense

Paying cash can be reasonable when a plan excludes the weight-management indication, when prior authorization is denied, or when the compounded route through a licensed pharmacy fits better clinically and financially. PlexusDx offers semaglutide and tirzepatide through its Weight Management Protocols, publishing per-protocol pricing on each product page so a self-pay patient can compare on the specifics rather than a single headline figure.

Genetics as the smarter first spend

If you are paying out of pocket, sequencing your spending matters. Understanding your metabolic wiring first can make every subsequent dollar more purposeful.

Upstream of any GLP-1 decision, the PlexusDx Precision Peptide Genetic Test reads 14 pathways, 49 peptides, 150+ genetic insights, mapping variants such as FTO, and MC4R that shape your baseline appetite, satiety, and energy-balance biology. It never predicts how you will respond to a specific drug, and it is not a drug-response predictor; it simply gives you the metabolic backdrop to bring into a provider conversation. That is the test-before-you-invest sequence PlexusDx applies to every protocol: understand the biology first, then weigh the options with a clinician rather than guessing. To see the compounded protocols that pair with that context, explore the Weight Management Protocols collection, all delivered through licensed 503A compounding.

Questions to ask before paying cash

Before committing to a self-pay route, a few questions sharpen the decision. Does the price include a provider evaluation and follow-up, or the drug alone? Is the product FDA-approved brand or a compounded formulation from a licensed 503A pharmacy? What happens if the dose changes or a side effect appears? For a cash payer, the total value of an offering is not just the sticker but the care wrapped around it. Comparing a bare-drug price against a supervised protocol on price alone can be misleading, so weigh what each option includes. Paying out of pocket rewards careful comparison more than any other payment path. Because there is no plan absorbing part of the bill, small differences in pharmacy pricing, coupon availability, or protocol structure translate directly into what you pay, which makes shopping the specifics genuinely worthwhile.

Frequently Asked Questions

How much is Wegovy without insurance?

List price is approximately $1,349 per month at U.S. list as of April 2026, per Novo Nordisk's published pricing. Without insurance or a savings card, cash-pay patients face close to that list figure. Pharmacy discount cards and compounded alternatives are the main ways to bring the number down.

Can I use a manufacturer savings card if I'm uninsured?

Usually not. Novo Nordisk's savings card is designed for eligible commercially-insured patients, so uninsured cash payers typically do not qualify. Because eligibility terms change, it is worth confirming directly on the manufacturer site rather than assuming, but plan on discount cards or compounding instead.

Are compounded versions cheaper for cash payers?

Often they price below brand list. Compounded semaglutide and tirzepatide from licensed 503A pharmacies use a separate pricing structure, and are legally and factually different from the brand, not generics. The trade-offs are regulatory complexity and variation in oversight, so review the specifics with a qualified clinician.

Does Medicare help with cash cost?

Not for weight alone. Medicare does not cover FDA-approved weight-management drugs for weight alone as of April 2026, though cardiovascular-indication coverage exists for some products. If you are on Medicare and self-paying for weight management, plan around list price, discount cards, and compounded options.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.